Structure |
Chemical Name |
CAS |
MF |
|
Demiditraz IMpurity |
944267-48-5 |
C19H18N2O |
|
Betamethasone EP Impurity F |
330157-04-5 |
C22H28O4 |
|
Capecitabine Impurity 8 |
|
|
|
Carfilzomib Impurity D |
|
|
|
Cefodizime Impurity 4 |
|
|
|
Cefradine impurity 5 |
1379292-16-6 |
C10H17NO2 |
|
Clopidogrel Impurity 13 |
2173294-69-2 |
C16H16ClNO5S2 |
|
DecitaBine Impurity 12 |
|
|
|
Erlotinib Impurity 28 |
|
|
|
Fosaprepitant Impurity 12 |
172673-19-7 |
C23H22F7N4O6P |
|
Ibuprofen Impurity 2 |
|
C13H18O2 |
|
Imatinib Impurity 9 |
|
|
|
Isavuconazole Impurity 22 |
|
|
|
Isavuconazole Impurity 28 |
|
|
|
Levothyroxine Impurity 16 |
909279-46-5 |
C15H11ClI3NO4 |
|
Linagliptin Impurity 42 |
|
|
|
PalBociclib Impurity 25 |
|
|
|
Posaconazole Impurity 13 |
357189-98-1 |
C37H40F2N8O6 |
|
Posaconazole Impurity 25 |
1042398-26-4 |
C16H19F2IO3 |
|
Posaconazole Impurity 42 |
357189-96-9 |
C36H40F2N8O5 |
|
Posaconazole Impurity 65 |
2947625-11-6 |
|
|
Pramipexole Dimer Impurity (Mixture of Diastereomers) |
1147937-31-2 |
C13H23N3S |
|
Sitafloxacin Impurity 1 |
|
|
|
Sitagliptin Impurity 25 |
|
|
|
sofosBuvir impurity 47 |
|
|
|
SofosBuvir Impurity 64 |
|
|
|
Tofacitinib Impurity W |
|
|
|
Trelagliptin Impurity 21 |
|
|
|
2-chloromethyl-4-(3-hydroxypropoxy)-3-methylpyridine |
117976-92-8 |
C10H14ClNO2 |
|
Oxytocin Impurity 3 |
|
|
|
Rosuvastatin Impurity 158 |
|
|
|
Rosuvastatin Impurity 139 |
|
|
|
Rosuvastatin Impurity 124 |
|
|
|
4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro- |
79617-95-1 |
C17H17Cl2N |
|
Ertapenem Impurity A(USP) |
|
|
|
D-Glutamic acid, 4-(cyanomethyl)-N-[(1,1-dimethylethoxy)carbonyl]-, 1,5-dimethyl ester, (4S)-rel- |
2740644-40-8 |
C14H22N2O6 |
|
2-hydroxy-3-oxobutyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate |
|
|
|
INDEX NAME NOT YET ASSIGNED |
2731089-65-7 |
C27H34N2O6 |
|
2-(2-ethoxy-3-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one |
|
|
|
Bumetanide Photodegradable Impurity 15 |
|
|
|
Bisoprolol Impurity 48 |
|
|
|
Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-amino-2-hydroxy-, methyl ester, (1S,2S,3R,4R)-, mono(trifluoroacetate) (salt) (9CI) |
357448-34-1 |
C17H29F3N2O6 |
|
Faropenem Impurity AB |
|
|
|
Nirmatrelvir Impurity 9 |
|
|
|
4-nitro-1H-Imidazole-2-carboxaldehyde |
33543-81-6 |
C4H3N3O3 |
|
1-CHLOROMETHYL-2,3,4-TRIMETHOXYBENZENE |
1133-49-9 |
C10H13ClO3 |
|
Bumetanide Impurity 19 |
|
|
|
Rocuronium Bromide Impurity 26 、27 |
|
|
|
Roxadustat Impurity 20 |
|
|
|
Ruxolitinib Impurity |
|
|
|
Sitagliptin Impurity 82 |
|
|
|
(1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran- 2-yl)ethyl)-3,7-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl 2,2-dimethylbutanoate |
|
|
|
Perospirone Impurity 21 |
|
|
|
Perospirone Impurity 11 |
|
|
|
Dolutegravir Impurity 21 |
|
|
|
Related impurities of fluoxetine sodium 6 |
|
|
|
Fondaparinux sodium impurity 7 |
|
|
|
Fondaparinux sodium impurity 3 |
|
|
|
Oxacillin sodium Impurity B |
|
|
|
Revefenacin Impurity 21 |
|
|
|
trans N-Benzyl Paroxetine |
105813-14-7 |
C26H26FNO3 |
|
Lasmiditan Impurity 10 |
|
|
|
Nilotinib N-Oxide Impurity 3 |
|
|
|
Pemetrexed Impurity 51 |
|
|
|
6-((S)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-7-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
|
|
(S)-Tamsulosin Hydrochloride |
106463-19-8 |
C20H29ClN2O5S |
|
2,2'-Bisnalmefene |
176220-84-1 |
C42H48N2O6 |
|
4-Desmethoxypropoxyl-4-chloro Rabeprazole |
168167-42-8 |
C14H12ClN3OS |
|
N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture) |
110025-28-0 |
C25H27NO2 |
|
Rebeprazole sulfone N-oxide |
924663-37-6 |
C18H21N3O5S |
|
4-(4-Hydroxy-3,5-diiodphenoxy)-3,5-diiodphenylessigsure |
67-30-1 |
C14H8I4O4 |
|
4-Methoxyglucobrassicin |
83327-21-3 |
C17H22N2O10S2 |
|
4-methylsulfinylbenzoate |
33963-58-5 |
C8H8O3S |
|
Capecitabine Related Compound C |
|
|
|
Glycopyrrolate Erythro Isomer |
201667-20-1 |
|
|
5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine |
91147-46-5 |
C11H10ClN5 |
|
(S)-(+)-3-HYDROXYTETRAHYDROFURAN |
79107-75-8 |
C4H8OS |
|
4-Chlor-3-nitro-5-sulfobenzoesure |
130262-91-8 |
C7H4ClNO7S |
|
4-(4-Methylpiperazin-1-ylmethyl)benzoic acid |
106261-48-7 |
C13H18N2O2 |
|
α,α-Diphenylpiperidin-4-methanolhydrochlorid |
1798-50-1 |
C18H22ClNO |
|
3-(2-amino-1-hydroxyethyl)benzene-1,2-diol |
73660-93-2 |
C8H11NO3 |
|
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile |
641571-12-2 |
C12H8F3N3 |
|
17-BETA-ESTRADIOL 3-METHYL ETHER |
1474-53-9 |
C19H26O3 |
|
7-Epi-10-oxo-docetaxel (Docetaxel Impurity D) |
162784-72-7 |
C43H51NO14 |
|
(3-CHLORO-3-PHENYL-PROPYL)-DIMETHYL-AMINE HYDROCHLORIDE |
79130-51-1 |
C11H16ClN |
|
(Dimethylamino)acetaldehyde Dimethyl Acetal |
38711-20-5 |
C6H15NO2 |
|
Dasatinib N-Oxide |
910297-52-8 |
C22H26ClN7O3S |
|
(R)-9-[2-(DIETHYLPHOSPHONOMETHOXY)PROPYL] ADENINE |
180587-75-1 |
C13H22N5O4P |
|
P-TOLYL-PROPYNOIC ACID ETHYL ESTER |
52188-06-4 |
C12H12O2 |
|
cis-N-Methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine hydrochloride |
79617-89-3 |
C17H17Cl2N.HCl |
|
2,4-DIMETHYLDIPHENYLSULFIDE |
16704-47-5 |
C14H14S |
|
Dibenz[b,e]oxepin-11(6H)-on |
4504-87-4 |
C14H10O2 |
|
2-CHLORO-1-(4,5-DICHLORO-2-THIENYL)ETHAN-1-ONE |
64218-50-4 |
C6H3Cl3OS |
|
(5Z,7E)-9,10-Seco-26,27-cyclo-1α,3β-dihydroxycholesta-5,7,10(19)-trien-24-one |
126860-84-2 |
C27H40O3 |
|
(-)-3-Demethylcolchicine |
7336-33-6 |
C21H23NO6 |
|
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic acid methyl ester |
42019-07-8 |
C18H17ClO4 |
|
1,3-Dimethyl-5,5-diallylhexahydropyrimidine-2,4,6-trione |
722-97-4 |
C12H16N2O3 |
|
Pseudomonic acid C |
71980-98-8 |
C26H44O8 |
|
D,L-O-DesMethyl Venlafaxine-d6 |
1062605-69-9 |
C16H19D6NO2 |
|
(E)-3-[p-Bromomethylphenyl]acrylic acid ethyl ester |
78712-67-1 |
C12H13BrO2 |